Cartesian Therapeutics, Inc.RNACNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 17 | 85↑412.6% | 111↑30.2% | 26↓76.5% | 39↑49.6% |
| Gross Profit | 17 | 85↑412.6% | 109↑27.8% | 26↓76.1% | 39↑49.6% |
| Operating Income | -57 | -5↑91.9% | 15↑416.2% | -86↓694.4% | -44↑49.2% |
| Net Income | -69 | -26↑62.7% | 35↑237.7% | -220↓721.0% | -77↑64.8% |
| EBITDA | -66 | -5↑92.1% | 40↑872.4% | -235↓690.0% | -76↑67.7% |
| EPS Diluted | -20.42 | -6.60↑67.7% | 3.00↑145.5% | -49.76↓1758.7% | -3.29↑93.4% |